BRIEF-Txcell obtains authorization to restart Ovasave phase IIb clinical trial
May 25, 2016 at 11:48 AM EDT
* Obtains authorization from European regulatory authorities to restart Ovasave phase IIb clinical trial Source text for Eikon: Further company coverage: (Gdynia Newsroom)
